ABEONA THERAPEUTICS INC.
For the period ended Dec 31, 2024. Filed Mar 20, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 20, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
Our corporate headquarters are located in Cleveland, Ohio, where we currently lease approximately 62,000 square feet of manufacturing, laboratory and office space. That lease expires in December 2030. We also lease 10,400 square feet of office space located in New York, New York. That lease expires in September 2025 and has been sublet as of December 31, 2024.
In addition, we have signed a lease for approximately 16,566 square feet of office space with a commencement date of January 1, 2025. That lease expires in December 2030. This additional space will allow the Company to convert office space at the existing lease into additional manufacturing space to increase pz-cel manufacturing capacity.
We believe that our facilities are sufficient to meet our current needs and that suitable space will be available as and when needed for potential commercialization.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.